This is why Summit Therapeutics (SMMT) is one of the Best Stocks to buy in a Rising Market

Summit Therapeutics (NASDAQ:SMMT) is one of the best stocks to buy in a rising market, according to Wall Street analysts. On April 21, analysts at Stifel reiterated a Buy rating on Summit Therapeutics (NASDAQ:SMMT) and a $45 price target.

The positive stance comes on the heels of Akeso announcing plans to disclose HARMONi-6 interim Overall Survival readout at ASCO 2026. The disclosure is to optimize the setup better than when HARMONi-2 interim OS was disclosed last year as a result of an NMPA approval.

This is why Summit Therapeutics (SMMT) is one of the Best Stocks to buy in a Rising Market

Romaset/Shutterstock.com

Unlike Harmoni 2, Harmoni-6 features 33% larger sample size and all-squamous histology. The study provides a first look at an emerging OS from an ivonescimab Phase 3 trial randomized against anti-PD-1 tislelizumab. Last year, HARMONi-2 analyzed ivonescimab against monotherapy pembrolizumab in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).

Akeso is seeking label expansion for Ivonescimab in China, following an interim analysis requested by Chinese health authorities that showed a clinically meaningful positive trend favoring Ivonescimab over Pembrolizumab in PD-L1.

Summit Therapeutics (NASDAQ:SMMT) is a clinical-stage biopharmaceutical company focused on developing novel oncology therapies to treat serious, unmet medical needs. Their primary focus is the development and commercialization of ivonescimab, a potential first-in-class bispecific antibody targeting PD-1 and VEGF for the treatment of non-small cell lung cancer (NSCLC).

While we acknowledge the risk and potential of SMMT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SMMT and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 11 Best TSX Stocks to Buy According to Hedge Funds and 8 Best Australian Stocks to Buy in 2026.

Disclosure: None. Follow Insider Monkey on Google News.